Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Axcan completes acquisition of worldwide Photofrin rights

June 13, 2000

Onyx commences phase III clinical trial of CI-1042 to treat H&N cancer

June 13, 2000

Novogen anticancer drug advances to phase Ib

June 13, 2000

Scotia reports improved complete tumor response rate with Foscan PDT

June 13, 2000

New thiazole derivatives for inhibiting cell adhesion

June 9, 2000

Data presented this week on antiproliferative activity and mechanism of action of CT-3

June 9, 2000

Bioniche uncovers new class of agents with anticancer activity

June 9, 2000

Discovery of new generation of ribozymes and compound with potent activity against HER-2 oncogene

June 9, 2000

ISIS-2503 under clinical evaluation, alone and in combination, for advanced cancers

June 8, 2000

Available clinical data on tgDCC-E1A summarized; new formulation heads for clinic

June 8, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...